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Gold  (Au)  nanostructures  have  received  considerable  attention  in  recent  years  due  
to  their  advantageous chemical and physical properties  and potential applications in 
cancer  diagnosis  and treatment. Easily controllable size, geometry, and nontoxicity of 
Au nanostructures enable their diverse array of biomedical applications.  
Cancer  stem  cells  (CSCs)  are  subpopulations  of  cells  within  tumors  that  drive  
tumor  growth, metastasis  and  recurrence.  CSCs  are  resistant  to  many  current  
cancer  treatments,  including chemo  and  radiation therapy.  As  these  cells  are  both  
invasive  and  highly  tumorigenic,  it  has been  hypothesized  that  the  inability  to  
efficiently  eliminate  CSCs  during  conventional  therapy may result in disease relapse 
and formation of metastases. Recent studies have described new treatment modalities to 
deliver therapeutic payloads directly to CSCs using nanoparticles.  
Despite the successful use of Au nanoparticles for cancer therapy both in vitro and in 
vivo, their CSC targeting capability remain largely unexplored.  The  objective  of  this  
project  is  to investigate  the  significance  of  shape,  size,  and  culture  time  in  the  
distribution  of  Au  nanoparticles  in  CSCs and non-CSCs and to  understand  the 









Cancer Stem Cell Persistence  
 Although they only constitute a small portion of a tumor, cancer stem  cells 
(CSCs) are believed to  be  responsible  for  the  origin,  growth,  recurrence,  and  
metastasis  of  cancer.  Current anticancer therapies (e.g., chemotherapy and radiation 
treatment) have been demonstrated to be ineffective against CSCs due to their 
indiscriminate cytotoxicity.  More recently, studies have shown that conventional 
therapies enrich the CSC population due to their inherent resistance against these 
treatment regimes.  This  leads  to  high  rates  of  tumor  relapse  and  ultimate  treatment 
failure (1). These limitations have provided incentives to develop effective anti-cancer 
strategies to target CSCs. 
Gold Nanoparticles for Cancer Therapy 
 Nanoparticle-mediated delivery of chemotherapeutic  agents  has demonstrated  
enhanced anticancer  efficacy  while  simultaneously  reducing  side  effects  of  cancer  
treatment.  Although nanoparticles  with  the  proper  structures,  sizes,  and  surface  
properties  have  been  shown  to accumulate  and  retain  in  solid  tumors,  the  
importance  of  particle  size  and  structure  in  this  process remain largely unexplored. 
 
 We have chosen Au nanoparticles for initial studies due to their low cytotoxicity, 
size and shape controlled  synthesis,  uniformity,  and  well-developed  surface  
chemistry.  Current  studies  have demonstrated the use of Au nanoparticles for a  wide 
range of biomedical applications, including RNA interference therapy and programmed 
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cell death  (2,  3).  Recently,  Xia and Li  (4)  reported theranostic  applications  of  Au  
nanoparticles  in  photoacoustic  imaging  and  as  a  photothermal agent and drug 
delivery vehicle. 
 Previous research has already shown  that  cellular  uptake of Au nanoparticles 
depends  on their particular  shape,  size,  and  surface  ligands  (5-7).  Nanoparticles with 
the proper structure and size readily accumulate and retain in solid tumors.  However, it 
is still not clear whether the size and shape characteristics of Au nanoparticles influence 
their uptake by CSCs (8). In addition, comparative uptake of different Au nanostructures 
(spherical, cubic and other shapes) by CSCs has not been investigated.  In  this  study,  
we  aimed  to  investigate  the  size  and  shape dependence  of  Au  nanoparticle  uptake  
into  CSCs  and  non-CSCs.  The results of this research may help optimize maximal 
biodistribution of the particles for an increased anti-tumor capability. 
Research Objective 
 The objective of this study is to characterize the biodistribution of Au 
nanoparticles  in CSCs  and  non-CSCs.  In  order  to  compare  the  cellular  
internalization  of  nanoparticles  with different  shape  and  size  and  understand  the  
related  mechanism  of  internalization,  Au nanoparticles with varying 3-D shape and 
size will be synthesized. Figure 1 shows transmission electron microscopy (TEM) images 
of Au nanospheres, Au nanocages and Au nanorods.  The aqueous suspensions of these 
nanoparticles will be incubated with CSCs  and  non-CSCs  and the  amount  of  particles  




Figure 1: The Transmission Electron Microscopy (TEM) Images of Different Nanoparticles: 
(a) Au nanospheres, (b) Au nanocages and (c) Au nanorods. 
 
In the first stage of this project, 20, 50, and 100 nm au nanospheres were synthesized. 
Figure 2 shows TEM images of Au nanospheres with different sizes. The Au 
nanoparticles were then conjugated with polyethylene glycol (PEG) to prevent 
agglomeration by interaction with plasma proteins during the culture (9). MDA-MB-435 
cells derived from mice breast cancer tissue were cultured  in  serum-free  DMEM-F12  
medium  that  contained  a  supplement  of  nutrients,  growth factors and hormones.  
This culture condition induced the cancer cells to form mammospheres (spherical 
collection of cells) and enriched the CSCs from about 5% to 50%. The mammosphere 
cells were incubated in Au nanoparticle solutions for varying lengths of culture time. 
these cells were  then  labeled  with  ALDH1  (a  marker  for  breast  CSCs)   and  CSCs  







Figure 2: The Transmission Electron Microscopy (TEM) Images of Au Nanospheres with 
Different Sizes: (a) 20 nm, (b) 50 nm and (c) 100 nm. 
 
CHAPTER 2 
MATERIALS AND METHODS  
Materials  
Hexadecyltrimethylammonium  bromide  (CTAB,  >98.0%), 
hexadecyltrimethylammonium  chloride (CTAC,  >98.0%), MeOH, 5-bromosalicylic acid 
(5-BrSA, >98.0%),  hydrogen  tetrachloroaurate  trihydrate  (HAuCl4·3H2O),  sodium  
salicylate  (NaCreso, 99%),  L-ascorbic  acid  (>99.5%),  silver  nitrate  (AgNO3,  >99%),  
sodium  borohydride  (NaBH4, 99%),  hydrochloric  acid  (HCl,  37  wt%  in  water),  
silver  trifluoroacetate  (CF3COOAg,  >98%),  sodium  hydrosulfide  hydrate  (NaHS)  
and  polyvinylpyrrolidone  (PVP,  MW≈55,000)  were purchased  from  sigma  aldrich.  
Sodium chloride (NaCl,  99.9%)  was  acquired  from  Fisher, Fairlawn,  NJ.  Trans-2-[3-
(4-tert-butylphenyl)-2-methyl-2-propenylidene] malononitrile (DCTB) was obtained 
from Santa Cruz Biotechnology and used as received.  Ethylene glycol (EG) was 
acquired from J. T. Baker (lot no. G32B27).   Methoxy-terminated PEG-thiol (1 mM, 
mPEG-SH) was purchased from Laysan Bio. Inc. DMEM-F12 media and supplements 
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were purchased from Invitrogen.  Ultrapure  water  with  a  resistivity  of  18.2  MΩcm  
produced  with  Milli-Q  Integral  5 system was used in all experiments. All glassware 
was rinsed extensively with ultrapure water and dried before use. 
Synthesis of Gold Nanorods 
The seed solution for AuNRs was prepared as follows (10, 11): A 5 mL amount of 0.5 
mM HAuCl4 was mixed with 5 mL of 0.2 M CTAB solution. A 0.6 mL portion of fresh 
0.01 M NaBH4 was then quickly injected into the Au (III)-CTAB solution without 
stirring. The solution color changed from yellow to brownish-yellow. The seed solution 
was aged at room temperature for 30 min before use. 
To prepare the growth solution, 0.9 g of CTAB together with defined amounts of 
additives were dissolved in 25 mL of warm water (60
o
C) in a 100 mL round flask. The 
solution was allowed to cool to 30
o
C after a 4 mM AgNO3 solution was added. The 
mixture was kept undisturbed  at 30
o
C for 15 min, after which 25 mL of 1 mM HAuCl4  
solution and, if necessary, a small amount of HCl  (37  wt%  in  water,  12.1  M)  was  
added.  After  15  min  of  slow  stirring  (400  rpm),  0.064  M ascorbic  acid  (Table  1)  
was  added,  and  the  solution  was  vigorously  stirred  for  30  s  until  it became  
colorless.  The  growth  solution  had  a  CTAB  concentration  of  about  0.05  M  and 
was used right after preparation. Table 1 shows the required amounts of each chemical 
for different sizes of nanorods. 
Finally, 0.08 mL of seed solution was injected into the growth solution. The resultant 
mixture was  stirred  for  30  s  and  left  undisturbed  at  30
o
C  for  12  h  for  nanorod  
growth.  The  reaction products  were  isolated  by  centrifugation  at  8,500  rpm  for  25  
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min  followed  by  removal  of  the  supernatant. The precipitates were redispersed in 10 
mL of water. 
Table 1: Reagent Requirements Table: Shows the required amounts of each chemical for 
different sizes of nanorods.  
 
Synthesis of Gold Nanospheres 
Preparation of the initial CTAB-Capped Au Seeds was as follows (12): The Au seeds 
were prepared by adding an ice-cold aqueous solution of NaBH4 (0.6 mL, 10 mM) into 
an aqueous solution of HAuCl4 (10 mL, 0.25 mM) and CTAB (100 mM). A brown 
solution immediately formed upon the introduction of NaBH4. Then, the mixture was left 
undisturbed at 27
o
C for 3 h to ensure the complete decomposition of any NaBH4 that 
remained in the reaction mixture.  
In a standard synthesis of 10 nm Au nanospheres, an aqueous solution of   HAuCl4  (2 
mL, 0.5 mM), an aqueous solution of CTAC (2 mL, 200 mM),  and an aqueous solution 
of AA (1.5 mL, 100 mM) were mixed in a  glass  vial (20 mL), followed by the addition 
of the initial seeds (100 mL). The  reaction was allowed to proceed at 27
o

















0.08 0.60 0.10 
Length:33.0 ± 2.5             




0.08 2.40 0.20 
49.0 ± 4.0 




0.04 1.80 0.20 
52.5 ± 3.5 
12.0 ± 0.5 
828 
0.11g 5-BrSA 
+ 0.21 mL 
HCl 
0.04 2.40 0.125 
101.7 ± 7.5 
15.9 ± 0.8 
1057 
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The product was collected by centrifugation at 14,500 rpm for 30 min and washed once 
with water. 
For the synthesis of 20  nm Au nanospheres, an aqueous solution of  HAuCl4  (2 mL, 
0.25 mM), an aqueous solution of CTAC (2 mL, 200 mM), and an aqueous solution of 
AA (1.5 mL, 50 mM) were mixed in a vial (20 mL), followed by the addition of the as-
prepared suspension of 10 nM Au nanospheres (100 mL, before washing). The reaction 
was allowed to proceed at 27
o
C for 10 min. The final  product  was  collected  by  
centrifugation  at  14,500  rpm for  10  min  and  washed once with water.  Protocol for 
50 and 100 nm nanospheres has recently been submitted (13). 
Synthesis of Gold Nanocages 
Preparation of Silver Nanocubes. 
Single-crystal seeds of Ag were prepared using a recently reported polyol process  (14-
16)  with ethylene  glycol  (EG)  as  the  solvent  and  CF3COOAg  as  a  precursor  to  
elemental  silver.  In  a typical  synthesis,  5  mL  EG  was  added  into  a  100  mL  round  
bottom  flask  and  heated  under magnetic stirring in an oil bath pre-set to 150 °C, and 
then 0.06 mL NaHS (3 mM in EG) was quickly injected. After 2 min, 0.5 mL HCl (3 mM 
in EG) was injected into the heated solution, followed by the addition of 1.25 mL of poly 
(vinyl pyrrolidone) (20 mg/mL in EG). After another 2 min, 0.4 mL CF3COOAg (282 
mM in EG) was added into the mixture.  During the entire process, the  flask  was  
capped  with  a  glass  stopper  except  the  addition  of  reagents.  The  cubic  seeds were 
obtained by quenching the reaction with an ice-water bath when the major LSPR peak of 
the Ag seeds had reached 399 nm and 435 nm, respectively. After centrifugation and 
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washing with  acetone  and  deionized  water  three  times,  the  seeds  were  stored  in  
EG.  The  particle concentration  of  Ag  seeds  was  determined  using  a  combination  
of  TEM  imaging  (for  size measurement) and ICP-MS, for the Ag concentration. 
Titration of Silver Nanostructures with HAuCl4 Solution. 
In  a  typical  procedure  (17,  18),  a  100  µl  aliquot  of  the  as-obtained  dispersion  of  
silver nanocubes  (or  250  µl  for  the  nanowires  or  spherical  nanoparticles)  was  
added  to  5  ml  of deionized  water.    This  diluted  dispersion  of  silver  nanocubes  
was  then  refluxed  for  10  min before a specific volume of 1 mm HAuCl4  aqueous 
solution was added  dropwise. The mixture was refluxed for another 20 min until its color 
became stable. Vigorous magnetic stirring was maintained in the entire process. As the 
solution was cooled to room temperature, white solids AgCl precipitates was found to 
settle at the bottom of the container.  The AgCl solid could be removed by dissolving 
with a saturated solution of NaCl.  In this case, NaCl powders were added to the  aqueous  
dispersion  of  product  until  it  was  saturated  with  NaCl. The  solution  was  then 
transferred into a tube and centrifuged at 10,000 rpm for 15 min. The supernatant 
containing the dissolved AgCl could be easily removed using a pipe.  The  solid  was  
rinsed  with  water  and centrifuged  six  more  times  and  finally  dispersed  with  water  
for  further  characterization  and usage. 
PEGylation 
The  PEG-modification  was  prepared  by  adding  0.3  mL  of  1  mM  mPEG-SH 
(Laysan Bio Inc., Arab, AL) to 1 mL of the as-prepared or as obtained Au nanoparticles 
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at room temperature. After 12 h, the PEG-modified Au nanoparticles were separated by 
centrifugation and redispersed in deionized water. 
Internalization 
MDA-MB-435 breast cancer stem cells were enriched in serum-free DMEMF12 media 
with growth factors. Figure 3 shows images of adherent cells and mammospheres of 
MDA-MB-435 cells.  The mammosphere  cells  were  treated with  Au  nanospheres  
with  different sizes for various  culture  times. The CSCs and non-CSCs in 
mammospheres were separately collected using BD Biosciences FACS Aria III cell 
sorter. The number of Au nanoparticles taken up by the cells was then quantified using 
ICP-MS for both CSCs and non-CSCs.  
 







In this stage of the project, we tested only nanospheres of different sizes (20, 50, and 100 
nm) in MDA-MB-435 CSCs and non-CSCs.  We found that the internalization of Au 
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nanospheres is time and size-dependent in both CSCs and non-CSCs.   Higher 
internalization efficiency is defined as having higher distribution of particles within CSCs 
than non-CSCs. 
Although the highest internalization efficiency was achieved at 6 h incubation period 
with 20 nm nanospheres,  internalization efficiency was also  higher  at  other time points 
assessed (0.5, 1, 2, and  4  h)  as  compared  to  50  and  100  nm  nanostructures.  Figure 
4 shows internalization efficiency of tested Au nanospheres. 
 
Figure 4: The Internalization Efficiency of Au Nanospheres with Different Sizes by CSCs 
and non-CSCs in Vitro. The amount of nanospheres in the cells was determined by ICP-MS 
analysis. Highest internalization efficiency was achieved at 6 h incubation period with 20 nm 




Nanoparticles  are  increasingly  used  in  biomedical  applications  ranging  from  drug  
delivery  to cellular imaging  (4,  18).  Their size and shape have been shown to be 
important in their CSC targeting  capacity.  In  this  preliminary  work,  we  investigated  
size  and  time-dependent  cellular internalization  of  Au  nanospheres  into  CSCs.  Our  
results  showed  that  cellular  uptake  of  Au nanospheres  by CSCs  is  size  and time-
dependent.  Although internalization rate of  all sizes of Au  nanospheres  in  CSCs  were  
higher  than  that  observed  for  non-CSCs  at  all time  points assessed,  the  highest  
internalization  efficiency  was  observed  at  6  h  with  20  nm  Au nanospheres.  This 
shows that longer contact and smaller size of Au nanospheres are important for an 
increased CSC  internalization  efficiency.  The internalization process  by cells (both 
CSCs and  non-CSCs)  is  mostly  like  through  the  process  of  endocytosis.  We will 
repeat  these experiments for the consistency of results.  It is highly possible that presence 
of different Au nanoparticles in the medium could affect the cellular  uptake  of  each  
other.  Also,  in  these  applications,  nanoparticles  are  exposed  to  a complex cellular 
environment and this may alter nanoparticle–cell interactions  (8).  Therefore, a large 
number of in vitro experiments need to be conducted to compare differential 
internalization of  nanostructures  with  different  sizes  and  shapes  alone  or  in  
combination  and  interaction  of nanoparticles with extracellular proteins should be taken 
into consideration.  Once  internalization  rate  and  pattern  of  different  Au  
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nanostructures  are  identified,  in  vivo experiment will be designed to test tumor  
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